Search For "phase iii"
Bharat Biotech completes clinical development for phase III trials, booste
Updated : 2 days, 10 hours ago IST
Hyderabad (Telangana) [India], August 15 (ANI): Bharat Biotech International on Monday said that BBV154 (intranasal vaccine) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.
Read More
Bharat Biotech's COVID-19 nasal vaccine phase III trials completed
Updated : 1 month, 4 weeks ago IST
Paris [France], June 19 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India (DCG
Read More
Delhi Police bust IPL betting racket, arrest six persons
Updated : 2 months, 3 weeks ago IST
New Delhi [India], May 22 (ANI): Delhi Police busted an IPL betting racket in Chander Vihar, Phase-III, Nihal Vihar on Sunday and arrested six persons engaged in it.
Read More
Ayush Ministry to start phase-III clinical trial on efficacy of Ayurveda i
Updated : 4 months, 3 weeks ago IST
New Delhi [India], March 23 (ANI): To examine the efficacy of Ayurveda in the treatment of Rheumatoid Arthritis, the Ministry of Ayush is going to conduct the world's first multicenter phase III clinical trial over the subject.
Read More
Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI
Updated : 5 months ago IST
New Delhi [India], March 18 (ANI): Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources.
Read More
AstraZeneca booster dose works against Omicron, says Oxford lab study
Updated : 7 months, 3 weeks ago IST
London [UK], December 23 (ANI): The University of Oxford, in collaboration with AstraZeneca, has announced interim trial data from its Phase III trials that show its candidate coronavirus vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of
Read More
Patients with high-risk local melanomas benefit from immunotherapy drug: S
Updated : 11 months ago IST
Pennsylvania [US], September 20 (ANI): According to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center, immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma.
Read More
Optimus announces Interim Clinical Results from Phase III Clinical Trials
Updated : 1 year ago IST
Hyderabad (Telangana) [India], July 21 (ANI/PNN): Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild Covid-19 patients.
Read More
DCGI likely to approve phase 3 trial data of Covaxin on Tuesday
Updated : 1 year, 1 month ago IST
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin on Tuesday, sources said.
Read More
Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III trials, say s
Updated : 1 year, 1 month ago IST
New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources.
Read More
DCGI's expert panel to review Phase III data of Covaxin today
Updated : 1 year, 1 month ago IST
New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat Biotech's Covaxin on Tuesday.
Read More
Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt
Updated : 1 year, 1 month ago IST
New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources.
Read More